EDITAS MEDICINE INC.
2.3800
25-November-24 15:45:01
15 minutes delayed
Stocks
-0.0600
-2.46%
Today's range
2.3450 - 2.5300
ISIN
N/A
Source
NASDAQ
-
Editas Medicine Announces Third Quarter 2021 Results and Business Updates
08 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Bernadette Connaughton to Board of Directors
28 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update
25 Oct 2021 15:01:00 By Nasdaq GlobeNewswire
-
07 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
30 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
29 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Emma Reeve to Board of Directors
08 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
07 Sep 2021 15:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
02 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
20 Aug 2021 15:20:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2021 Results and Business Updates
04 Aug 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update
28 Jul 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
26 Jul 2021 08:00:00 By Nasdaq GlobeNewswire
-
23 Jun 2021 06:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2021 15:01:00 By Nasdaq GlobeNewswire
-
14 Jun 2021 08:00:01 By Nasdaq GlobeNewswire